Paloma Partners’s Bausch Health BHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-100
| Closed | -$2K | – | 1146 |
|
|
2022
Q1 | $2K | Sell |
100
-34
| -25% | -$831 | ﹤0.01% | 1708 |
|
|
2021
Q4 | $4K | Buy |
+134
| New | +$3.59K | ﹤0.01% | 1856 |
|
|
2021
Q3 | – | Sell |
-150,329
| Closed | -$4.41M | – | 1120 |
|
|
2021
Q2 | $4.41M | Buy |
150,329
+130,136
| +644% | +$3.94M | 0.08% | 221 |
|
|
2021
Q1 | $641K | Buy |
+20,193
| New | +$592K | 0.01% | 956 |
|
|
2020
Q4 | – | Sell |
-14,218
| Closed | -$221K | – | 1662 |
|
|
2020
Q3 | $221K | Buy |
+14,218
| New | +$245K | 0.01% | 1688 |
|
|
2020
Q2 | – | Sell |
-12,565
| Closed | -$196K | – | 2070 |
|
|
2020
Q1 | $196K | Buy |
+12,565
| New | +$303K | 0.01% | 906 |
|
|
2019
Q4 | – | Sell |
-19,857
| Closed | -$516K | – | 2149 |
|
|
2019
Q3 | $434K | Buy |
+19,857
| New | +$454K | 0.01% | 1269 |
|
|
2018
Q4 | – | Sell |
-108,870
| Closed | -$2.59M | – | 1288 |
|
|
2018
Q3 | $2.79M | Buy |
+108,870
| New | +$2.49M | 0.05% | 338 |
|
|
2018
Q2 | – | Sell |
-41,062
| Closed | -$654K | – | 1639 |
|
|
2018
Q1 | $654K | Buy |
+41,062
| New | +$764K | 0.01% | 1218 |
|
|
2017
Q4 | – | Sell |
-19,926
| Closed | -$286K | – | 1884 |
|
|
2017
Q3 | $286K | Buy |
19,926
+4,026
| +25% | +$60.9K | ﹤0.01% | 1824 |
|
|
2017
Q2 | $275K | Sell |
15,900
-12,096
| -43% | -$145K | ﹤0.01% | 1840 |
|
|
2017
Q1 | $310K | Buy |
+27,996
| New | +$385K | ﹤0.01% | 1727 |
|
|
2016
Q2 | – | Sell |
-54,158
| Closed | -$1.53M | – | 2154 |
|
|
2016
Q1 | $1.42M | Buy |
54,158
+23,337
| +76% | +$1.73M | 0.02% | 659 |
|
|
2015
Q4 | $3.13M | Buy |
30,821
+24,942
| +424% | +$2.8M | 0.08% | 215 |
|
|
2015
Q3 | $1.05M | Sell |
5,879
-2,253
| -28% | -$525K | 0.02% | 626 |
|
|
2015
Q2 | $1.81M | Sell |
8,132
-21,868
| -73% | -$4.85M | 0.03% | 487 |
|
|
2015
Q1 | $5.96M | Buy |
30,000
+2,458
| +9% | +$436K | 0.17% | 106 |
|
|
2014
Q4 | $3.94M | Buy |
27,542
+22,442
| +440% | +$3.02M | 0.17% | 129 |
|
|
2014
Q3 | $669K | Sell |
5,100
-804
| -14% | -$95.8K | 0.03% | 438 |
|
|
2014
Q2 | $747K | Buy |
5,904
+3,604
| +157% | +$460K | 0.03% | 418 |
|
|
2014
Q1 | $303K | Buy |
+2,300
| New | +$314K | 0.02% | 507 |
|
|
2013
Q4 | – | Sell |
-15,200
| Closed | -$1.58M | – | 1006 |
|
|
2013
Q3 | $1.58M | Sell |
15,200
-74,929
| -83% | -$7.3M | 0.06% | 256 |
|
|
2013
Q2 | $7.77M | Buy |
+90,129
| New | +$7.1M | 0.43% | 52 |
|
Other funds holding BHC
IC
PC
VH
GAM
LCM
KKRC
Paloma Partners's BHC Position: Q2 2022 in Review
Paloma Partners sold out of Bausch Health (BHC) in Q2 2022, closing a stake of 100 shares — an estimated $2K sold.
Paloma Partners first reported a position in BHC in Q2 2013 and held it in 23 quarters. The position peaked at $7.77M in Q2 2013. 327 funds tracked by Wall St. Rank hold BHC as of Q2 2022.
- Paloma Partners reported no remaining Bausch Health position as of Q2 2022 after selling out during the quarter.
- Paloma Partners sold 100 Bausch Health shares in Q2 2022, an estimated $2K.
- Paloma Partners first reported a position in Bausch Health in Q2 2013 and held it in 23 quarters.
- Paloma Partners's Bausch Health position peaked at $7.77M in Q2 2013.
- 327 funds tracked by Wall St. Rank held Bausch Health as of Q2 2022.
Based on Paloma Partners's 13F filing for Q2 2022, filed 15 Aug 2022.